Andere talen HeartBeam, Inc.

Aandelen

BEAT

US42238H1086

Vertraagde tijd Nasdaq Andere beurzen 16:27:39 16-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
2,13 ^USD	-0,93%		+5,97%	-9,36%

09/05	Transcript : HeartBeam, Inc., Q1 2024 Earnings Call, May 09, 2024
09/05	HeartBeam, Inc. rapporteert resultaten voor het eerste kwartaal dat eindigde op 31 maart 2024	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

HeartBeam AIMIGo Recognized for Digital Health Innovation in 8th Annual MedTech Breakthrough Awards Program	14/05
HeartBeam AIMIGo™ Recognized for Digital Health Innovation in 8th Annual MedTech Breakthrough Awards Program	13/05
HeartBeam Reports First Quarter 2024 Results	09/05
HeartBeam, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	09/05
HeartBeam to Host First Quarter 2023 Results Conference Call on Thursday May 9, 2024 at 4:30 p.m. Eastern Time	25/04
HeartBeam Presents Positive Results on its Artificial Intelligence Capabilities for Detecting Arrhythmias	09/04
HeartBeam, Inc. Presents Positive Results on its Artificial Intelligence Capabilities for Detecting Arrhythmias	09/04
HeartBeam : Fourth Quarter 2023 Earnings Conference Call Presentation	20/03
HeartBeam, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	20/03
HeartBeam Reports Fourth Quarter and Full Year 2023 Financial Results	20/03
First Patients Enrolled in Pivotal Study Evaluating HeartBeam's AIMIGo System for synthesizing a 12-Lead ECG	15/03
First Patients Enrolled in Pivotal Study Evaluating HeartBeam’s AIMIGo™ System for Synthesizing a 12-Lead ECG	14/03
HeartBeam, Inc. Announces First Patients Enrolled in Pivotal Study Evaluating HeartBeam's AIMIGo System for Synthesizing A 12-Lead ECG	14/03
HeartBeam Receives Two New US Patents for its Core Cardiac Monitoring Technology	07/03
HeartBeam, Inc. Receives Two New US Patents for Its Core Cardiac Monitoring Technology	07/03
HeartBeam to Host Fourth Quarter and Full Year 2023 Results Conference Call on Wednesday March 20, 2024 at 4:30 p.m. Eastern Time	05/03
HeartBeam, Inc. Announces Retirement of Richard Brounstein as Chief Financial Officer	05/02
HeartBeam Unveils AI Program Designed to Deliver Unprecedented Personalized Cardiac Insights	14/12
HeartBeam, Inc. Unveils AI Program Designed to Deliver Unprecedented Personalized Cardiac Insights	14/12
HeartBeam, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen HeartBeam, Inc.

Aandelen

BEAT

US42238H1086

Andere talen

Filters